| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 08/05/2003 | US6603026 Heterocyclic compounds produced from biomass |
| 08/05/2003 | US6603025 Used as intermediates for preparing fungicides |
| 08/05/2003 | US6603012 RAR selective retinoid agonists |
| 08/05/2003 | US6602914 Treatment of a disease that is mediated by the expression or suppression of a redox sensitive gene, for example MCP-1, IL-6 and thrombin receptor; antiinflammatory agents; cardio-vascular disorders; atherosclerosis; immunology |
| 08/05/2003 | US6602874 5-(2-(4-methylpiperazin-1-yl)-phenyl)- furan-2-carboxylic acid 4-chlorobenzylamide, for example; treating or preventing migraine, depression and other disorders for which a 5-HT1, agonist or antagonist is indicated |
| 08/05/2003 | US6602817 Combination approach to chiral reagents or catalysts having amine or amino alcohol ligands |
| 08/05/2003 | CA2275827C Method for treating glaucoma |
| 08/05/2003 | CA2125490C Antimetastasis agent of malignant tumors |
| 07/31/2003 | WO2003062228A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection |
| 07/31/2003 | WO2003062218A1 Method of obtaining citalopram |
| 07/31/2003 | WO2003062217A1 Catalyst and process for the oxidation of hydrocarbons |
| 07/31/2003 | WO2003062181A1 PROCESS FOR THE PREPARATION OF NONRACEMIC SYN-1-(4-HYDROXY-PHENYL)-2-(4-HYDROXY-4-PHENYL.PIPERIDIN-1Yl)-1-PROPANOL COMPOUNDS |
| 07/31/2003 | WO2003062180A1 Process for the preparation of nonracemic syn-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenyl-piperidin-1-yl)-1-propanol compounds |
| 07/31/2003 | WO2003061826A1 Process for preparing nonracemic chiral alcohols |
| 07/31/2003 | WO2003061824A1 Process for preparing nonracemic chiral alcohols |
| 07/31/2003 | WO2003041649A3 Cyanoalkylamino derivatives as protease inhibitors |
| 07/31/2003 | WO2003027061A3 Muscarinic agonists |
| 07/31/2003 | WO2002030863A3 Ether compounds and compositions for cholesterol management and related uses |
| 07/31/2003 | WO2002020500A3 Materials and methods to potentiate cancer treatment |
| 07/31/2003 | US20030144534 Selective extractions of citalopram or of its impurities with organic solvents and water under specific conditions of pH and temperature. The crude citalopram can be prepared by a process that comprises reacting |
| 07/31/2003 | US20030144526 Calcium receptor-active compounds |
| 07/31/2003 | US20030144523 Epothilone derivatives, method for producing same and their pharmaceutical use |
| 07/31/2003 | US20030144521 Hydrogenation of a corresponding nonracemic 1-(4-benzoxy phenyl)-2-(4-hydroxy-4- phenyl-piperidin-1-yl)-1-propanone using a catalyst system comprising ruthenium, a nonracemic diphosphine ligand, a bidentate amine ligand selected from |
| 07/31/2003 | US20030144504 Dialkyl-halogenophenyl-substituted ketoenols |
| 07/31/2003 | US20030144342 alpha- and beta-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 07/31/2003 | US20030144334 Cyclopentabenzofuran derivatives and their use |
| 07/31/2003 | US20030144217 Prodrugs of aspartyl protease inhibitors |
| 07/31/2003 | US20030144137 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation |
| 07/31/2003 | US20030143633 Factors participating in degranulation of mast cells, dnas encoding the same, method of screening of these factors and the inhibitors |
| 07/31/2003 | US20030143230 Combination of an IL-1/18 inhibitor with a TNF inhibitor for the treatment of inflammation |
| 07/31/2003 | US20030140431 3-(2,5-Diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 07/31/2003 | CA2474323A1 Method of obtaining citalopram |
| 07/31/2003 | CA2471389A1 Process for the preparation of nonracemic syn-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenyl-piperidin-1yl)-1-propanol compounds |
| 07/30/2003 | EP1331216A1 Monomers having electron-withdrawing groups and processes for preparing the same |
| 07/30/2003 | EP1330434A1 Process for the preparation of thiophenols |
| 07/30/2003 | EP0902022B1 Novel benzofuranone derivatives and process for producing the same |
| 07/30/2003 | EP0592439B1 Aminosulfonyl carbamates |
| 07/30/2003 | CN1433396A Pharmaceutical compounds |
| 07/30/2003 | CN1433394A Solvent exchange process |
| 07/30/2003 | CN1116291C Substituted tetracyclic tetrahydrofuran derivatives |
| 07/30/2003 | CN1116290C Process for preparing tetrahydrofuran from dialkoxybutenes |
| 07/30/2003 | CN1116271C Method of producing 2-substituted-3,4-fused heterocycle benzoic acid |
| 07/29/2003 | US6600070 Chemical intermediates for large cyclic lactone-based perfumes, formed by condensation reaction of gamma-butyrolactone with a dicarboxylate ester |
| 07/29/2003 | US6600058 Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments |
| 07/29/2003 | US6600053 Useful for producing polyimide precursors or polyimides having low thermal expansion and low residual stress |
| 07/29/2003 | US6600052 With a ring cyclizing reagent to form the compound of Formula V to yield a compound of Formula V: inhibitors of the cyclooxygenase- II enzyme. and antiinflammatory agents and analgesic pharmaceutical agents. |
| 07/29/2003 | US6599943 Preventive treatment, related to the radical generating nature of the xanthine dehydrogenase/xanthine oxidase |
| 07/29/2003 | US6599934 3,4-diaryl thiopenes and analogs thereof having use as antiinflammatory agents |
| 07/29/2003 | US6599932 Highly selective in killing tumor cells but not normal cells |
| 07/29/2003 | US6599925 Cardiovascular disorders; anticancer agents |
| 07/29/2003 | US6599918 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans |
| 07/29/2003 | US6599904 Sulphonamide derivatives, process for their preparation, and their use as medicaments |
| 07/29/2003 | CA2059449C Process for the synthesis of citroconimides |
| 07/24/2003 | WO2003060852A2 Catalytic osmium-assisted oxidative cleavage of olefins |
| 07/24/2003 | WO2003059915A2 ENANTIOSELECTIVE METHODS FOR PREPARING α- AND β-AMINO ACID DERIVATIVES |
| 07/24/2003 | WO2003059899A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof |
| 07/24/2003 | WO2003059889A1 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 07/24/2003 | WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/24/2003 | WO2003059875A2 DERIVATIVES OF α-PHENYLTHIOCARBOXYLIC AND α-PHENYLOXY-CARBOXYLIC ACIDS USEFUL FOR THE TREATMENT OF DISEASES RESPONDING TO PPARα ACTIVATION |
| 07/24/2003 | WO2003059340A1 Method for the preparation of lariciresinol, cyclolariciresinol and secoisolariciresinol |
| 07/24/2003 | WO2003059064A1 Insecticides containing hydrazone derivatives as the active ingredient and novel hydrazone derivatives |
| 07/24/2003 | US20030139614 Catalyzing the decyclization of racemic and diastereomeric epoxides mixtures in the presence of a non-racemic, chiral catalyst; pharmaceutical synthesis |
| 07/24/2003 | US20030139611 Column for concentrating phthalic anhydride |
| 07/24/2003 | US20030139605 Antiproliferative agents, treating or preventing osteoporosis, inflammation, and angiogenesis disorders, treating liver cancer |
| 07/24/2003 | US20030139594 Catalytic process for the modification of carbohydrates, alcohols, aldehydes or polyhydroxy compounds |
| 07/24/2003 | US20030139475 Novel tricyclic compounds and drug compositions containing same |
| 07/24/2003 | US20030139453 Difluorobutyric acid metalloprotease inhibitors |
| 07/24/2003 | US20030139425 Piperazine derivatives and their use as anti-inflammatory agents |
| 07/24/2003 | US20030139421 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
| 07/24/2003 | US20030139405 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | US20030139404 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents |
| 07/24/2003 | US20030139390 Compounds for the modulation of PPARgamma activity |
| 07/24/2003 | CA2700690A1 Process for producing reformatsky reagent in stable form |
| 07/24/2003 | CA2472746A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof |
| 07/24/2003 | CA2472223A1 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to pparalpha activation |
| 07/23/2003 | EP1329449A1 Column for the concentration of phtalic anhydride |
| 07/23/2003 | EP1328510A2 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 07/23/2003 | EP1328508A2 Propionic acid derivatives with ppar-alpha activating properties |
| 07/23/2003 | EP1328265A2 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions |
| 07/23/2003 | EP1204654B1 Benzofurylpiperazines: 5-ht2c serotonin receptor agonists |
| 07/23/2003 | EP1086096B1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors |
| 07/23/2003 | EP1025083B1 Process for stereoselective synthesis of prostacyclin derivatives |
| 07/23/2003 | EP0888278B1 Antidiabetic agents |
| 07/23/2003 | CN1431996A C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides |
| 07/23/2003 | CN1431941A 挤压模 Extrusion die |
| 07/23/2003 | CN1431915A Treatment of congestive heart failure with compsn. comprising diuretic agent and vasopressin antagonist |
| 07/22/2003 | US6596908 Degrading lignocellulose in oxygen; quenching |
| 07/22/2003 | US6596873 2-and 2,5-substituted phenylketoenols |
| 07/22/2003 | US6596863 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
| 07/22/2003 | US6596752 Inhibitors of α4β1 mediated cell adhesion |
| 07/22/2003 | US6596741 Compounds of formula I exhibit activity as serotonin, norepinephrine, and dopamine reuptake inhibitors and can be used in the treatment of central nervous system and other disorders. |
| 07/22/2003 | US6596722 Serotonin reuptake inhibitors/HT3 receptor antagonists useful for treatment of depression, psychosis, anxiety disorders, panic disorder, obsessive compulsive disorder, and eating disorders |
| 07/22/2003 | US6596716 2-propane-sulphonamide derivatives |
| 07/22/2003 | CA2353693C Pharmaceutical composition containing citalopram |
| 07/22/2003 | CA2245250C Benzofuran-acrylic acid derivatives and their use as modulators of rxrs or rars receptors |
| 07/17/2003 | WO2003057686A1 Alpha-methylenelactone synthesis in supercritical fluids |
| 07/17/2003 | WO2003057683A1 Methylenelactone synthesis in supercritical fluids |
| 07/17/2003 | WO2003057663A1 Preparation of alpha-diimines |
| 07/17/2003 | WO2003057254A1 Preventives/remedies for urinary disturbance |
| 07/17/2003 | WO2003057225A2 Phosphate transport inhibitors |